Medicap Laboratories

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• INCONSPICU1 refused line

  Required information not conspicuous

  Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Medicap Laboratories

Is Medicap Laboratories on an FDA import alert?

Yes. As of October 26, 2026, Medicap Laboratories is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for edica ezestro supplement; FDA published the listing on June 25, 2024.

Has FDA refused shipments from Medicap Laboratories?

Yes. FDA refused 1 shipment line from Medicap Laboratories on June 11, 2024. The most recent, on June 11, 2024, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as INCONSPICU (required information not conspicuous).

Why did FDA refuse Medicap Laboratories's shipments?

The most frequent charges are INCONSPICU (required information not conspicuous, 1 line) and NCONTACT (no u.s. adverse event contact on supplement label, 1 line).

What is Medicap Laboratories's FEI number?

Medicap Laboratories's FDA Establishment Identifier (FEI) is 3008064895.

Can shipments from Medicap Laboratories still enter the U.S.?

Shipments of edica ezestro supplement from Medicap Laboratories can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).